EP1007041A4 - Composition for treating pain - Google Patents

Composition for treating pain

Info

Publication number: EP1007041A4
Authority: EP; European Patent Office
Prior art keywords: composition; treating pain; pain; treating
Prior art date: 1997-04-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP98915497A

Other languages

German (de)

French (fr)

Other versions

EP1007041A1 (en

Inventor

Charles Howard Mitch

Per Sauerberg

Harlan Edgar Shannon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-11

Filing date

1998-04-10

Publication date

2001-03-07

1998-04-10 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

2000-06-14 Publication of EP1007041A1 publication Critical patent/EP1007041A1/en

2001-03-07 Publication of EP1007041A4 publication Critical patent/EP1007041A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

EP98915497A 1997-04-11 1998-04-10 Composition for treating pain Withdrawn EP1007041A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US4357497P	1997-04-11	1997-04-11
US43574P		1997-04-11
PCT/US1998/007293 WO1998046227A1 (en)	1997-04-11	1998-04-10	Composition for treating pain

Publications (2)

Publication Number	Publication Date
EP1007041A1 EP1007041A1 (en)	2000-06-14
EP1007041A4 true EP1007041A4 (en)	2001-03-07

Family

ID=21927854

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP98915497A Withdrawn EP1007041A4 (en)	1997-04-11	1998-04-10	Composition for treating pain

Country Status (4)

Country	Link
EP (1)	EP1007041A4 (en)
JP (1)	JP2002503224A (en)
AU (1)	AU6966998A (en)
WO (1)	WO1998046227A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE234090T1 (en) *	1998-11-13	2003-03-15	Lilly Co Eli	COMBINATION OF DULOXETINE WITH NON-STEROID ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF PAIN
ATE248166T1 (en)	1999-06-04	2003-09-15	Lilly Co Eli	7-OXO-2-AZABICYCLO(2.2.1)HEPTANES AS SELECTIVE MUSCARINE RECEPTOR ANTAGONISTS
US6465458B1 (en)	1999-07-01	2002-10-15	Pharmacia & Upjohn Company	Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor
DE102004011392A1 (en) *	2004-01-13	2005-08-04	Grünenthal GmbH	Weak to moderate opioids or combinations of these opioids with antidepressants for the treatment of depression, anxiety disorders and pain
GB0428170D0 (en) *	2004-12-23	2005-01-26	Biopartners Ltd	Mono and Combination Therapy
AU2008245836A1 (en) *	2007-04-30	2008-11-06	Adolor Corporation	Compositions of (-)-E-10-OH-NT and methods for their synthesis and use

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997020561A1 (en) *	1995-12-07	1997-06-12	Eli Lilly And Company	Composition for treating pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5418240A (en) *	1990-08-21	1995-05-23	Novo Nordisk A/S	Heterocyclic compounds and their preparation and use
MX9300875A (en) *	1992-02-20	1993-08-31	Smithkline Beecham Plc	PROCEDURE FOR THE PREPARATION OF AZABICICLIC COMPOUNDS.
FI960748A7 (en) *	1993-08-19	1996-04-18	Novo Nordisk As	Antipsychotic method

1998
- 1998-04-10 WO PCT/US1998/007293 patent/WO1998046227A1/en not_active Ceased
- 1998-04-10 JP JP54412698A patent/JP2002503224A/en active Pending
- 1998-04-10 AU AU69669/98A patent/AU6966998A/en not_active Abandoned
- 1998-04-10 EP EP98915497A patent/EP1007041A4/en not_active Withdrawn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997020561A1 (en) *	1995-12-07	1997-06-12	Eli Lilly And Company	Composition for treating pain

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9846227A1 *

Also Published As

Publication number	Publication date
AU6966998A (en)	1998-11-11
WO1998046227A1 (en)	1998-10-22
EP1007041A1 (en)	2000-06-14
JP2002503224A (en)	2002-01-29

Legal Events

Date	Code	Title	Description
2000-04-28	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-06-14	17P	Request for examination filed	Effective date: 19991111
2000-06-14	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2000-06-14	AX	Request for extension of the european patent	Free format text: AL PAYMENT 19991111;LT PAYMENT 19991111;LV PAYMENT 19991111;MK PAYMENT 19991111;RO PAYMENT 19991111;SI PAYMENT 19991111
2001-03-07	A4	Supplementary search report drawn up and despatched	Effective date: 20010124
2001-03-07	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2001-03-07	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 31/44 A, 7A 61K 31/435 B
2004-03-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2004-05-12	18D	Application deemed to be withdrawn	Effective date: 20031103

Publication	Publication Date	Title
EP0874828A4 (en)	1999-09-01	Composition for treating pain
GB9706486D0 (en)	1997-05-14	Hair treatment composition
HUP0101685A3 (en)	2003-04-28	Hair treatment composition
GB9622659D0 (en)	1997-01-08	Hair treatment composition
AU9035498A (en)	1999-03-16	Method for treating pain
IL126203A0 (en)	1999-05-09	Method for treating pain
EP0906104A4 (en)	2003-12-10	Method for treating pain
AU7582398A (en)	1998-12-11	Composition for treating skin conditions
ZA953256B (en)	1996-10-21	Skin treatment composition
GB2322550B (en)	2000-10-04	Hair treatment composition
GB9700899D0 (en)	1997-03-05	Novel treatment
ZA974462B (en)	1998-11-23	Floor treating composition
ZA952121B (en)	1996-09-16	Skin treatment composition
IL126064A0 (en)	1999-05-09	Method for treating pain
IL124419A0 (en)	1998-12-06	Composition for treating pain
AU9034798A (en)	1999-03-16	Method for treating pain
EP1007041A4 (en)	2001-03-07	Composition for treating pain
GB9707987D0 (en)	1997-06-11	Hair treatment compositions
GB2331528B (en)	2002-03-13	Hair treatment composition
EP0845975A4 (en)	2000-05-10	Hair treatment composition
AU7247898A (en)	1998-11-11	Composition for treating pain
GB9714841D0 (en)	1997-09-17	Treatment method
GB9810856D0 (en)	1998-07-22	Hair treatment composition
GB9705989D0 (en)	1997-05-07	Therapeutic composition
ZA952120B (en)	1996-09-16	Skin treatment composition